12.09.2025 • NewsinvestmentPharmaLGC Group

LGC Opens $100 Million Pharma Synthesis Center in Canada

LGC Group has inaugurated a CAD$100 million (€61.5 million) Organic Chemistry Synthesis Centre of Excellence in Vaughan, Canada, significantly expanding global capacity for advanced research chemicals to support the pharmaceutical and life sciences sectors.

Company representatives at the opening
Grand opening of LGC Group’s $100M Organic Chemistry Synthesis Centre of Excellence in Vaughan, Canada, expanding global research chemical and life sciences capabilities.
© LGC Group

LGC Group officially opened its new Organic Chemistry Synthesis Centre of Excellence in Vaughan, Ontario, following a CAD $100 million (€61.5 million)investment. The 203,000 ft² (17,200 m²) facility is one of the largest of its kind in the world and significantly expands Toronto Research Chemicals’ (TRC) capacity to serve pharmaceutical, biotechnology, and life sciences customers worldwide.

Founded more than 40 years ago and acquired by LGC in 2019, TRC is internationally recognised for its expertise in synthesising complex organic molecules, many of which are only available from TRC. These compounds underpin global drug discovery pipelines, diagnostic development, forensic testing, food and environmental safety, and industrial innovation, giving customers reliable access to critical building blocks for science.

“This $100 million investment is about building capacity at scale, giving our customers faster, more reliable access to the essential tools that enable breakthroughs,” said Joydeep Goswami, CEO of LGC Group. “From Vaughan, our scientists will help tackle challenges like precision medicine, PFAS detection, and sustainable chemistry, while supplying the world with solutions that protect health, food, and the environment.”

Impact for Customers Worldwide

Products manufactured at the new facility will be shipped to more than 170 countries, enabling research in areas such as cancer, infectious disease, mental health, and environmental safety. For customers, the expansion means greater reliability, scale, and speed of delivery at a time when the demand for high-quality, specialised research chemicals is growing rapidly.

“TRC’s science may start in our labs, but its impact is felt worldwide – in hospitals, communities, and industries that depend on reliable answers,” said Bruno Rossi, EVP and General Manager, LGC Standards. “With this new facility, we’re building on 40 years of expertise to deliver faster, broader, and more sustainable innovation for scientists everywhere.”

Company

Logo:

LGC Group

Priestley Centre, 10 Priestley Road
GU2 7XY Surrey Research Park, Guildford
UK

Company contact







Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.